News

Presents cutting-edge research at major conferences worldwide.
Portraitfoto von Stephan Kerkojus

Introducing Our New Business Director: Stephan Kerkojus

We are thrilled to announce that Stephan Kerkojus has joined our team as our new Business Director

Together with Bencard Allergie GmbH, Munich, Germany, ClinCompetence Cologne publishes the top line results of the first year of the 5-years cohort study TAPAS (Tyrosine Allergoid paediatric and adult study)

Together with Bencard Allergie GmbH, Munich, Germany, ClinCompetence Cologne publishes the top line results of the first year of the 5-years cohort study TAPAS (Tyrosine Allergoid paediatric and adult study)

The TAPAS study (“Tyrosine Allergoid Paediatric and Adult Study”) is a large, prospective, multicenter, long-term cohort study designed to evaluate the safety, tolerability, and efficacy of subcutaneous allergen immunotherapy (SCIT) with microcrystalline tyrosine-adsorbed allergoids (MATA) in children, adolescents, and adults suffering from seasonal allergic rhinitis due to grass or tree pollen.

read more

Job offers